Retraction Note: Effect of propofol on myocardial ischemia-reperfusion injury throughMAPK/ERK pathway

H-J Yan1, G-Q Qi, Y Ma

  • 1Department of Anesthesiology, Chengyang People's Hospital, Qingdao, China.

Insights

This study on propofol and myocardial ischemia-reperfusion injury is retracted due to inaccurate data and duplicated Western Blots. The authors could not provide original data, leading to manuscript retraction.

Area of Science:

  • Cardiology
  • Pharmacology
  • Molecular Biology

Background:

  • Myocardial ischemia-reperfusion injury is a significant clinical concern.
  • The mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway plays a role in cardiac injury.
  • Propofol's effects on this pathway warrant investigation.

Purpose of the Study:

  • To investigate the effect of propofol on myocardial ischemia-reperfusion injury.
  • To explore the involvement of the MAPK/ERK pathway in propofol's action.

Main Methods:

  • The study utilized Western Blot analysis to assess protein expression.
  • Specific figures (2 and 6) contained duplicated Western Blots, raising data integrity concerns.

Main Results:

  • The article reported findings on propofol's effect on myocardial ischemia-reperfusion injury via the MAPK/ERK pathway.
  • However, the data presented was found to be inaccurate.

Conclusions:

  • The study has been retracted due to significant data integrity issues.
  • The authors acknowledged discrepancies and could not provide original data for verification.